Benzimidazole

You have access
CCL299, a Benzimidazole Derivative Induces G₁ Phase Arrest and Apoptosis in Cancer Cells
YOSHIFUMI OHNO, RUIRONG YI, AKIKO SUGANAMI, YUTAKA TAMURA, AKIO MATSUMOTO, SHOJI MATSUMOTO, KENGO SAITO and HIROSHI SHIRASAWA

Anticancer Research February 2021, 41 (2) 699-706; DOI: https://doi.org/10.21873/anticanres.14821
You have access
Celecoxib and LLW-3-6 Reduce Survival of Human Glioma Cells Independently and Synergistically with Sulfasalazine
TOKUNBO YEROKUN and LEYTE L. WINFIELD

Anticancer Research December 2015, 35 (12) 6419-6424;
You have access
Synergism from Combinations of tris(benzimidazole) monochloroplatinum(II) Chloride with Capsaicin, Quercetin, Curcumin and Cisplatin in Human Ovarian Cancer Cell Lines
LAILA ARZUMAN, PHILIP BEALE, CHARLES CHAN, JUN Q. YU and FAZLUL HUQ

Anticancer Research October 2014, 34 (10) 5453-5464;
You have access
LLW-3-6 and Celecoxib Impacts Growth in Prostate Cancer Cells and Subcellular Localization of COX-2
TOKUNBO YEROKUN and LEYTE L. WINFIELD

Anticancer Research September 2014, 34 (9) 4755-4759;
You have access
Benzimidazole Analogs as Potent Hypoxia Inducible Factor Inhibitors: Synthesis, Biological Evaluation, and Profiling Drug-like Properties
JIANJUN CHEN, JIN WANG, LUCIANA P. SCHWAB, KYUNG-TAE PARK, TIFFANY N. SEAGROVES, LISA K. JENNINGS, DUANE D. MILLER and WEI LI

Anticancer Research August 2014, 34 (8) 3891-3904;

Main menu